Skip to main content
Pharmsville Co., Ltd. logo

Pharmsville Co., Ltd. — Investor Relations & Filings

Ticker · 318010 ISIN · KR7318010006 KO Manufacturing
Open in API
Filings indexed 129 across all filing types
Latest filing 2019-10-29 Major Shareholding Noti…
Country KR South Korea
Listing KO 318010

About Pharmsville Co., Ltd.

http://pharmsville.net/

Pharmsville Co., Ltd. is a bio-healthcare company that develops, produces, and sells health functional foods and natural supplements. Founded in 2000, the company focuses on extending human healthspan through the research and development of novel ingredients, with a specialization in microbiome-based probiotics. Its product portfolio is marketed to both domestic and international consumers under brands such as 'Appletree Dr.'. The company supports its innovation through dedicated research facilities, including the Pharmsville Bio Lab, aiming to create health products that are as natural as possible for the human body.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in accordance with Article 147 of the Capital Markets Act in South Korea. This type of filing is specifically used to notify regulatory bodies (Financial Services Commission and Korea Exchange) when an individual or entity crosses a significant ownership threshold in a listed company. Based on the provided filing categories, this document fits the definition of a 'Major Shareholding Notification' (MRQ).
2019-10-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 98% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea (often filed with the Financial Supervisory Service/DART) to report insider shareholdings, changes in ownership, and director/major shareholder transactions. Based on the provided categories, this aligns with 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2019-10-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). This is a standard regulatory filing used to disclose insider shareholdings and transactions by company directors or major shareholders. In the provided classification schema, this corresponds to 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2019-10-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). This type of filing is a standard regulatory disclosure for insider trading or changes in share ownership by company directors/executives. In the provided classification schema, this corresponds to 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2019-10-29 Korean
증권발행실적보고서
Share Issue/Capital Change Classification · 95% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. This document details the final results of a public offering, including subscription status, allocation, shareholding changes, and the use of proceeds. In the context of financial filings, this type of report is a regulatory requirement following a capital raise and falls under the category of 'Share Issue/Capital Change' (SHA) as it documents the issuance of new shares and the resulting changes in capital structure.
2019-10-15 Korean
투자설명서
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a '투자설명서' (Investment Prospectus) for a company named '주식회사 팜스빌' (Farmsville Co., Ltd.). It contains detailed information regarding a public offering of shares, including offering price, subscription period, risk factors (business, company, and investment risks), and management information. This is a formal regulatory document filed for an IPO or public offering, which falls under the 'Proxy Solicitation & Information Statement' (PSI) category in the provided schema, as it serves as the primary disclosure document for investors to make informed decisions regarding a securities offering.
2019-10-01 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.